Evidence map›Paper›PMID 40970514›Full record

ArticleAging cell2025

Prematurely Aged Human Microglia Exhibit Impaired Stress Response and Defective Nucleocytoplasmic Shuttling of ALS Associated FUS.

Christiane Hartmann, Christina Haß, Muriel Knobloch, Israel Barrantes, Laura Fumagalli, Jessie Premereur, Franz Markert, Maite Peters, Georgia Koromila, Alexander Hartmann and 7 more

Abstract read
In one paragraph

Article in Aging cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Christiane HartmannTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, Rostock, Germany.ORCID 0000-0001-8699-0794
Christina HaßTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, Rostock, Germany.
Muriel KnoblochTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, Rostock, Germany.
Israel BarrantesInstitute for Biostatistics and Informatics in Medicine and Aging Research, Rostock University Medical Center, Rostock, Germany.
Laura FumagalliDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.ORCID 0000-0002-9333-926X
Jessie PremereurDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Franz MarkertDepartment of Neurology, Rostock University Medical Center, Rostock, Germany.ORCID 0000-0001-6502-2567
Maite PetersTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, Rostock, Germany.
Georgia KoromilaTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, Rostock, Germany.
Alexander HartmannInstitute of Clinical Chemistry and Laboratory Medicine, Rostock University Medical Center, Rostock, Germany.
Kathrin JägerInstitute of Clinical Chemistry and Laboratory Medicine, Rostock University Medical Center, Rostock, Germany.
Jette AbelTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, Rostock, Germany.
Renzo MancusoDepartment of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Alexander StorchDepartment of Neurology, Rostock University Medical Center, Rostock, Germany.ORCID 0000-0002-1133-9216
Michael WalterInstitute of Clinical Chemistry and Laboratory Medicine, Rostock University Medical Center, Rostock, Germany.
Georg FuellenInstitute for Biostatistics and Informatics in Medicine and Aging Research, Rostock University Medical Center, Rostock, Germany.
Andreas HermannTranslational Neurodegeneration Section "Albrecht Kossel", Department of Neurology, Rostock University Medical Center, Rostock, Germany.

Funding

Deutsche Forschungsgemeinschaft DFG91b
6 · The paper itself

Abstract

Microglia, the brain's resident immune cells, are crucial for maintaining healthy brain homeostasis. However, as the brain ages, microglia can shift from a neuroprotective to a neurotoxic phenotype, contributing to chronic inflammation and promoting neurodegenerative processes. Despite the importance of understanding microglial aging, there are currently few human in vitro models to study these processes. To address this gap, we have developed a model in which human microglia undergo accelerated aging through inducible progerin expression. HMC3-Progerin cells display key age-related markers such as activation of the senescence-associated secretory phenotype (SASP) as well as an increase in DNA damage. These prematurely aged HMC3 cells show a reduced response to LPS activation, exhibit impairments in essential microglial functions including decreased migration and phagocytosis as well as transcriptomic alterations including a shift observed in aging and neurodegeneration. Additionally, we observed an impaired stress response and a defect in nucleocytoplasmic transport, especially affecting the amyotrophic lateral sclerosis (ALS) associated protein FUS. This suggests that microglia play a contributory role in driving neurodegenerative processes in the aging brain. Our microglia aging model offers a valuable tool for exploring how aged microglia affect brain function, enhancing our understanding of their role in brain aging.

Indexed as

Amyotrophic Lateral SclerosisCellular SenescenceMicrogliaRNA-Binding Protein FUSStress, PhysiologicalActive Transport, Cell NucleusHumansPhagocytosisRNA-Binding Protein FUSagingaging clockamyotrophic lateral sclerosisFUSmicroglianucleocytoplasmic shuttlingprogerinsenolytics

Identifiers

PMID40970514
PMCPMC12610945

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.